Antibody response of patients with Severe Acute Respiratory Syndrome (SARS) targets the viral nucleocapsid

Journal of Infectious Diseases

Volumn 190, Issue 2, 2004, Pages 379-386

  Leung, Danny Tze Ming ^a   Tam, Frankie Chi Hang ^a   Chun, Hung Ma ^a   Chan, Paul Kay Sheung ^a   Cheung, Jo Lai Ken ^a   Niu, Haitao ^a   Tam, John Siu Lun ^a   Pak, Leong Lim ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; SARS CORONAVIRUS; SCHOOL CHILD; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS NUCLEOCAPSID; VIRUS VIRULENCE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR WEIGHT; NUCLEOCAPSID; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS;

EID: 3242706539     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422040     Document Type: Article

References (23)

1. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348:1995-2005.
2. Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-25.
3. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-66.
4. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
5. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003; 300:1399-404.
6. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300:1394-9.
7. Ruan YJ, Wei CL, Ee LA, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003; 361: 1779-85.
8. Bonavia A, Zelus BD, Wentworth DE, Talbot PJ, Holmes KV. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J Virol 2003; 77:2530-8.
9. Narayanan K, Maeda A, Maeda J, Makino S. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol 2000; 74:8127-34.
10. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
11. Torres JM, Sanchez C, Sune C, et al. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 1995; 213: 503-16.
12. Lamarre A, Talbot PJ. Protection from lethal coronavirus infection by immunoglobulin fragments. J Immunol 1995; 154:3975-84.
13. Castilla J, Sola I, Enjuanes L. Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies. J Virol 1997; 71:5251-8.
14. Feng N, Lawton JA, Gilbert J, et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specifk IgA mAb. J Clin Invest 2002; 109:1203-13.
15. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/ csr/sars/casedefinition/en/print.html. Accessed 1 May 2003.
16. Chan PKS, Tam JS, Lam CW, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis 2003; 9:1058-63.
17. + anti-DNA antibodies reconstructed by phage display. Gene 2000; 255:373-80.
18. Daginakatte GC, Chard Bergstrom C, Andrews GA, Kapil S. Production, characterization, and uses of monoclonal antibodies against recombinant nucleoprotein of elk coronavirus. Clin Diagn Lab Immunol 1999; 6:341-4.
19. Ndifuna A, Waters AK, Zhou M, Collisson EW. Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus. J Virol Methods 1998; 70:37-44.
20. Nakanaga K, Yamanouchi K, Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol 1986; 59:168-71.
21. Burns JW, Siadat Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996; 272:104-7.
22. Eleouet JF, Slee EA, Saurini F, et al. The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis. J Virol 2000; 74:3975-83.
23. von Grotthuss M, Wyrwicz LS, Rychlewski L. mRNA cap-1 methyltransferase in the SARS genome. Cell 2003; 113:701-2.